NUVA - ニュ―ベイシブ (NuVasive Inc.)

NUVAのニュース

   Allegro Microsystems and CubeSmart Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600  2022/12/02 22:15:00 S&P Global Platts
NEW YORK, December 2, 2022: S&P Dow Jones Indices (“S&P DJI”) will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 19 to coincide with the quarterly rebalance: • Allegro Microsystems Inc. (NASD:ALGM) and CubeSmart (NYSE:CUBE) will replace Semtech Corp. (NASD: SMTC) and NuVasive Inc. (NASD: NUVA) respectively in the S&P MidCap 400. Semtech and NuVasive will replace Diversified Healthcare Trust (NASD:DHC) and Tupperware Brands Corp. (NYSE:TUP) respectively in the S&P SmallCap 600.
   NuVasive to Participate in Piper Sandler 34th Annual Healthcare Conference  2022/11/16 12:00:00 PR Newswire
SAN DIEGO, Nov. 16, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will participate…
   NuVasive PT Lowered to $58 at RBC Capital  2022/11/10 11:42:01 Investing.com
https://www.investing.com/news/pro/nuvasive-pt-lowered-to-58-at-rbc-capital-432SI-2939640
   NuVasive, Inc. (NUVA) Q3 2022 - Earnings Call Transcript  2022/11/10 02:52:04 Seeking Alpha
NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q3 2022 Earnings Conference Call November 09, 2022, 04:30 PM ET Company Participants Juliet Cunningham - Vice President-Investor Relations Chris Barry -…
   NuVasive, Inc. Q3 Earnings Summary  2022/11/09 21:28:00 Finanz Nachrichten
WASHINGTON (dpa-AFX) - Below are the earnings highlights for NuVasive, Inc. (NUVA):Earnings: -$1.98 million in Q3 vs. -$21.64 million in the same period last year. EPS: -$0.04 in Q3 vs. -$0.42 in …
   NuVasive PT Lowered to $53 at Needham & Company  2022/09/30 11:48:01 Investing.com
https://www.investing.com/news/pro/nuvasive-pt-lowered-to-53-at-needham--company-432SI-2902871
   Orthopedic Implants Market Size Worth $67.23 Billion, Globally, by 2028 at 5.6% CAGR - Exclusive Research Report by The Insight Partners  2022/09/28 11:30:00 Benzinga
NEW YORK , Sept. 28, 2022 /PRNewswire/ -- The Insight Partners published latest research study on " Orthopedic Implants Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, End User, and Geography", the global orthopedic implants market size is expected to grow from $46.10 Billion in 2021 to $67.23 Billion by 2028; it is expected to grow at a CAGR of 5.6% from 2022 to 2028. Download Sample Brochure of Orthopedic Implants Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00024316/ Orthopedic Implants Market Report Scope, Segmentations, Regional & Country Scope: Report Coverage Details Market Size Value in US$ 46.10 Billion in 2021 Market Size Value by US$ 67.23 Billion by 2028 Growth rate CAGR of 5.6% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021 No. of Pages 150 Historical data available Yes Segments covered Product, Application, End User, and Geography Regional scope North America; Europe; Asia Pacific; Latin America; MEA Country scope US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends Companies Covered DJO Finance LLC; Johnson & Johnson (DePuy Synthes); Medtronic Plc; Zimmer Biomet Holdings, Inc.; Stryker Corporation; NuVasive, Inc.; CONMED Corporation; Smith and Nephew Plc; Arthrex, Inc.; Globus Medical, Inc.
   NuVasive Inc. (NUVA) will benefit from these strategies  2022/08/31 11:32:00 US Post News
NuVasive Inc. (NASDAQ:NUVA) closed Tuesday at $43.76 per share, up from $43.56 a day earlier. While NuVasive Inc. has overperformed by 0.46%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NUVA fell by -26.35%, with highs and lows ranging from $64.43 to $42.91, whereas the simple […]
   VNDA On Watch, NUVA Q2 Results Miss Estimates, MRTX Awaits FDA Decision...  2022/08/04 09:25:05 RTT News
NuVasive Inc. (NUVA), a company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, has reported lower-than-expected earnings and sales for the second quarter of 2022.
   NuVasive, Inc. (NUVA) CEO Chris Barry on Q2 2022 Results - Earnings Call Transcript  2022/08/04 01:37:12 Seeking Alpha
NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Juliet Cunningham – Vice President-Investor Relations Chris Barry – Chief…
   VNDA On Watch, NUVA Q2 Results Miss Estimates, MRTX Awaits FDA Decision...  2022/08/04 09:25:05 RTT News
NuVasive Inc. (NUVA), a company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, has reported lower-than-expected earnings and sales for the second quarter of 2022.
   NuVasive, Inc. (NUVA) CEO Chris Barry on Q2 2022 Results - Earnings Call Transcript  2022/08/04 01:37:12 Seeking Alpha
NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Juliet Cunningham – Vice President-Investor Relations Chris Barry – Chief…
   NuVasive, Inc. 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:NUVA)  2022/08/03 22:37:12 Seeking Alpha
The following slide deck was published by NuVasive, Inc.
   Recap: NuVasive Q2 Earnings  2022/08/03 20:44:53 Benzinga
NuVasive (NASDAQ: NUVA ) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings NuVasive missed estimated earnings by 16.07%, reporting an EPS of $0.47 versus an … Full story available on Benzinga.com
   NuVasive, Inc. Q2 Earnings Summary  2022/08/03 20:40:00 Finanz Nachrichten
WASHINGTON (dpa-AFX) - Below are the earnings highlights for NuVasive, Inc. (NUVA):Earnings: -$0.89 million in Q2 vs. $1.80 million in the same period last year. EPS: -$0.02 in Q2 vs. $0.03 in the…

calendar